Pharmaceutical Technology Europe-07-01-2007

Pharmaceutical Technology Europe
Manufacturing & Processing

July 01, 2009

A number of commentators during the past few years have speculated that nanotechnology is the wave of the future in biotech and pharma.

Pharmaceutical Technology Europe
Analytical Equipment

July 01, 2007

Traditionally, in pharmaceutical water systems the main method for controlling bacterial levels was heat or chemical sanitants...

Pharmaceutical Technology Europe
Supply Chain

July 01, 2007

Drug companies have come to realize that spending heavily on creating new blockbuster drugs is risky and less cost-effective ...

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe
Manufacturing & Processing

July 01, 2007

Driven by a rapidly ageing population and a known high consumption of pharmaceuticals, the French pharmaceutical market has always appeared buoyant.

Biopharmaceuticals
Pharmaceutical Technology Europe

July 01, 2007

... the biotech industry could make characterization of its products easier by paying more attention to downstream processing and purification issues, creating a cleaner product that is easier to identify.

News
Pharmaceutical Technology Europe

July 01, 2007

Anyone familiar with the USA v Barr Laboratories case of 1993 will recognize the importance of not ignoring OOS results, and the inappropriateness of testing into compliance.

Pharmaceutical Technology Europe

Vendors who insist on using older and outdated technologies will eventually suffer increased pressure to follow the lead of those who adopt new technologies.

Pharmaceutical Technology Europe
Manufacturing & Processing

July 01, 2007

Chitosan is of pharmaceutical interest because of its positive attributes with respect to toxicity, biocompatibility and bioavailability.